TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA"), a Phase 3 immune-oncology company developing novel technologies to ...

Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the ...

Auron will present data highlighting the activity of AUTX-703, its oral, potent and selective degrader targeting KAT2A/B in cell lines and patient derived organoid models (PDXO) of neuroendocrine ...

Ify, a student within the Faculty of Education Health and Wellbeing School of Health and Society, presented her research to academics, clinicians, patients and other attendees at the Cancer Research ...

Allegro’s microparticle hydrogel hydrocelin has the potential to be a first-in-class disease-modifying injectable treatment ...

Dr. Charles Olomofe, visiting assistant professor of Public Health, had an abstract accepted for poster presentation at the annual conference of the Society for Epidemiologic Research (SER), in Boston ...

For more and to view the abstract, visit the AACR Annual Meeting website. As previously announced, on December 11, 2024, TuHURA entered into a definitive agreement with Kineta, Inc. (OTC Pink ...

Lilo & Stitch kicked off the Disney presentation at CinemaCon, debuted a new clip, and the best poster of the year.

As part of his award, Jose will will receive a composting bucket from the city of Royal Oak and will also be honored with a tree planted at Oakland Elementary in his name on Friday, April 25, ...

The International Society of Stem Cell Research (ISSCR) is pleased to recognize Alice Rossi, PhD, Francis Crick Institute, UK ...